Navigation Links
Premier Research Names Hal Ward, R.Ph., PharmD as Executive Director, Global Pharmacovigilance

PHILADELPHIA, May 26 /PRNewswire/ -- Premier Research Group Limited, the international pharmaceutical services company, announces the appointment of Hal Ward, R.Ph., PharmD as Executive Director, Global Pharmacovigilance. In this position, he will lead the global pharmacovigilance team ensuring the delivery of quality medical and safety services.

Hal brings to Premier Research a wealth of experience in global safety monitoring, clinical and post marketing surveillance, and drug safety compliance and training programs. For the past three years, he has served as the Executive Director and Global Head of Drug Safety at Covance Late Stage Development Services Clinical Division where he had overall responsibility for the Drug Safety organization, including accurate and timely regulatory reporting, implementation of quality assurance and quality improvement plans, implementation of training and SOP programs, measurement of productivity and workload efficiency, and client satisfaction. Prior to joining Covance in 2006, Hal led the Global Medical Affairs Compliance Training team at Wyeth. He also led the Drug Safety Training team at Wyeth's Global Safety Surveillance and Epidemiology Division. Prior to that, he led the gastrointestinal team at Astra Merck's Product Safety and Epidemiology division.

"We are very pleased to have Hal joining our team in this important role," said James Ottinger, Vice President, Global Consulting and Compliance. "His expertise and proven leadership will strengthen our team and help us expand our pharmacovigilance services to meet the evolving needs of our clients."

About Premier Research

Premier Research is a leading global solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. They are leaders in clinical research for analgesia, CNS, oncology, and infectious disease and have a wealth of experience in medical device and pediatric research.

Premier Research has 32 offices and operates in more than 30 countries across North America and Europe employing more than 1,200 clinical professionals dedicated first and foremost to fulfilling each client's requirements in a timely, accurate, and cost-effective manner. This includes a strong international network of monitors and project management professionals combined with regulatory, data management, statistical, scientific and medical experts, and staff at our well-established network of dedicated clinical sites.

SOURCE Premier Research Group Limited
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services
2. Premier Research Appoints Melissa Jones as Vice President, International Business Development
3. Premier Research Appoints Global Head of Human Resources
4. Product Development Timelines and Commercialization Strategy Are Focus of New Group at Premier Research
5. Premier Research Names Patrick Melvin as Senior Director, Clinical Trial Management
6. Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons
7. Premier Research Group plc and Octagon Research Solutions, Inc. Announce Strategic Partnership
8. Premier Research Names Anthony Faragasso, MD as Executive Director and Global Head of Medical Management and Safety
9. Premier Research Announces Completion of Management Buyout
10. GANIC Pharmaceuticals Launched with Premier Pharmaceutical Industry Executives
11. Premier Healthcare Alliance Honors Siemens Healthcare Diagnostics for Excellence in Supplier Performance
Post Your Comments:
(Date:11/24/2015)... SAN DIEGO , Nov. 24, 2015 Halozyme Therapeutics, ... Jaffray Healthcare Conference in New York on ... Dr. Helen Torley , president and CEO, will provide a ... New York at 1:00 p.m. ET/10:00 a.m. ... communication and investor relations, will provide a corporate overview. --> ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... healthy metabolism. But unless it is bound to proteins, copper is also toxic ... (NIH), researchers at Worcester Polytechnic Institute (WPI) will conduct a systematic study of ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... IIROC on behalf of the Toronto Stock Exchange, confirms ... there are no corporate developments that would cause the ... --> --> About Aeterna Zentaris ... . --> Aeterna Zentaris is a specialty ...
(Date:11/24/2015)... PUNE, India , November 24, 2015 ... to a new market research report "Oligonucleotide Synthesis Market ... Equipment), Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User ... to 2020", published by MarketsandMarkets, the market is expected ... 1,078.1 Million in 2015, at a CAGR of 10.1% ...
Breaking Biology Technology:
(Date:11/17/2015)... , November 17, 2015 ... 19 novembre  2015.  --> Paris , ... --> DERMALOG, le leader de l,innovation biométrique, a ... fois passeports et empreintes sur la même surface de ... passeports et l,autre pour les empreintes digitales. Désormais, un ...
(Date:11/12/2015)... Nov. 12, 2015  A golden retriever that stayed ... dystrophy (DMD) has provided a new lead for treating ... the Broad Institute of MIT and Harvard and the ... . Cell, pinpoints a protective ... the disease,s effects. The Boston Children,s lab of ...
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
Breaking Biology News(10 mins):